Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dose-finding study of sugammadex and neostigmine for reversal of residual neuromuscular blockade
2009-013499-29Phase 4Completed
- Sponsor
- Technical University of Munich
- Start
- Aug 2009
- Modality
- Small Molecules, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4 trial of Sugammadex, glycopyrronium and neostigmine in neuromuscular block (NMB) (3 arms), sponsored by Technical University of Munich. Started Aug 2009; status: completed.
02
Drugs
Sugammadexglycopyrroniumneostigmine
03
Conditions
neuromuscular block (NMB)
Beyond the preview
Go deeper on 2009-013499-29.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-013499-29.